big pharma
More speciality drugs are coming onto the market than ever before. Why?
The number of drugs picking up a designation from regulators -- first treatments or speciality drugs -- across the European…
Pharmaceutical scandals: US states are suing the OxyContin manufacturer
The US states of New Hampshire and South Carolina are suing Purdue Pharma, the manufacturer of OxyContin for its role…
Humira — the highest gross-selling drug in the world — isn’t done yet
Humira has set a record for the highest gross-selling drug in the world and contributed 63 percent to AbbVie’s revenue…
Which class of drugs is set to have the biggest impact on the cancer market?
Cancer therapy was historically dominated by chemotherapy and hormonal therapies, but now a new drug class is poised to seize…
Sanofi is about to explode into the global dermatology market
Over the next few years Sanofi will go from being an also-ran in the dermatology arena to being a major…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Will a Brexit Health Alliance be able to protect the UK medical industry?
In the lead up to the UK’s departure from the EU, efforts are being made to ensure the stability of…
The Great British Brexodus: is the UK facing a Brexit brain drain?
As divorce talks between the UK and the European Union get underway, the country could soon be deprived of some of…
Antibiotic resistance: Could we be looking at the death of medicine?
Heart surgery, prenatal care, organ transplants, and blood transfusions. These are all lifesaving treatments that we will need to say…
Licensing deals are dominating the pharmaceutical landscape
In recent years licensing deals have dominated the pharmaceutical industry. Taking into account the growth in research and drug development…
In less than ten years the number of biosimilar trials has grown by more than 1,000 percent
Biosimilar trials -- testing an almost identical copy of a drug originally manufactured by a different company -- have exploded…